Bupivacaine HCl 
      
      
      	
      		- 
      			
Post Date:
      			Mar 21,2023
      		 
      		- 
      			
Expiry Date:
      			Mar 20,2024
      		 
      		- 
      			
Detailed Description:
      			
      				Cas No. :14252-80-3
			        Quantity: 9Metric Tons 
			        Specs:USP34
			        Price:23 USD Metric Tons
			        Payment Method: T/T,L/C.etc
			        Bupivacaine HCl 
14252-80-3
					  
      		 
      		  
      		- 
      			
CAS Registry Number:
      			
      				
      					14252-80-3
      				
      			
      		 
      		
      		
      		- 
      			
Synonyms:
      			;1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide;1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide hydrochloride;Bupivocoine HCl;1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride (1:1);1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride;Bupivacaine Hcl;2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride;2',6'-Pipecoloxylidide, 1-butyl-, hydrochloride (6CI);Marcaina;BUPIVACAINE HYDROCHLORIDE ANHYDROUS;
      		 
      		
      		
      		- 
      			
Molecular Formula:
      			C18H31ClN2O2
      		 
      		
  				
  				- 
      			
Molecular Weight:
      			342.9039
      		 
      		
      		
  				- 
      			
Molecular Structure:
    				
	    				
	    					
	    				
	     				
   					    
  				 
  				
  				
  				- 
      			
Hazard Symbols:
    				
 T+:Very toxic;
  				 
 				 	  
				      
				  - 
      			
Risk Codes:
    				R26/27/28:;
  				 
  				  
				    
				  - 
      			
Safety Description:
				    S22:;
S36/37/39:;
S45:;
				   
				   
      	
       
      
      	
      		- 
      			
Company:
      			
      				Anhui Dexinjia Biopharm Co.,Ltd.
    					        
    						
      			
      		 
      		- 
      			
Contact:
				    Haiyao Guo
				   
				  - 
      			
Tel:
				    0531-82375880
				   
				  - 
      			
Fax:
				    0531-82375893
				   
				  - 
      			
Email:
				    haiyao@jndxj.com
				   
      	
       
      Inquiry